Search…

China antibody-B (03681.HK) completes the issuance of 24.9654 million subscribed shares.

29/08/2025

The China Antigen-B (03681.HK) announced on the Zhitong Financial APP that it had completed the issuance of 24.9654 million subscribed shares on August 29, 2025, with a subscription price of HK$2.03 per share.

Latest

now

Guohai Securities: Net profit in the first half of 2025 increased by 159.26% year-on-year.

now

Alibaba's pre-market gains in US stocks have expanded to nearly 7%. The management of Alibaba stated in a conference call that the monthly active users of Taobao's flash sale have reached 300 million, an increase of 200% compared to April. In the next three years, flash sales and instant retail are expected to bring in 1 trillion yuan in new transactions.

1 m ago

The Silk Road Culture Group Limited (00472.HK) announced its interim results. The attributable loss to owners decreased by about HK$41.727 million, representing a 19.67% decrease compared to the same period last year.

1 m ago

China Bioengineering (01237.HK) announces interim results with a net profit attributable to shareholders of 8.752 million yuan, reversing from a loss to a profit year-on-year.

2 m ago

Zhizheng Co., Ltd. (603991.SH) released its semi-annual financial results, with a net loss attributable to shareholders of 22.65 million yuan.

+852 - 60190728

Customer Support

Commercial Services